These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 34432807)

  • 1. Multi-omics subtyping pipeline for chronic obstructive pulmonary disease.
    Gillenwater LA; Helmi S; Stene E; Pratte KA; Zhuang Y; Schuyler RP; Lange L; Castaldi PJ; Hersh CP; Banaei-Kashani F; Bowler RP; Kechris KJ
    PLoS One; 2021; 16(8):e0255337. PubMed ID: 34432807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omics and the Search for Blood Biomarkers in Chronic Obstructive Pulmonary Disease. Insights from COPDGene.
    Regan EA; Hersh CP; Castaldi PJ; DeMeo DL; Silverman EK; Crapo JD; Bowler RP
    Am J Respir Cell Mol Biol; 2019 Aug; 61(2):143-149. PubMed ID: 30874442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease.
    Zhao P; Li J; Yang L; Li Y; Tian Y; Li S
    Mol Med Rep; 2018 Apr; 17(4):5247-5257. PubMed ID: 29393428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update.
    Ghosh N; Dutta M; Singh B; Banerjee R; Bhattacharyya P; Chaudhury K
    Expert Rev Mol Diagn; 2016 Aug; 16(8):897-913. PubMed ID: 27267972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine Learning Characterization of COPD Subtypes: Insights From the COPDGene Study.
    Castaldi PJ; Boueiz A; Yun J; Estepar RSJ; Ross JC; Washko G; Cho MH; Hersh CP; Kinney GL; Young KA; Regan EA; Lynch DA; Criner GJ; Dy JG; Rennard SI; Casaburi R; Make BJ; Crapo J; Silverman EK; Hokanson JE;
    Chest; 2020 May; 157(5):1147-1157. PubMed ID: 31887283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotyping of Chronic Obstructive Pulmonary Disease Based on the Integration of Metabolomes and Clinical Characteristics.
    Kilk K; Aug A; Ottas A; Soomets U; Altraja S; Altraja A
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of multi-omics datasets enables molecular classification of COPD.
    Li CX; Wheelock CE; Sköld CM; Wheelock ÅM
    Eur Respir J; 2018 May; 51(5):. PubMed ID: 29545283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD.
    Zhang Z; Wang J; Li Y; Liu F; Chen L; He S; Lin F; Wei X; Fang Y; Li Q; Zhou J; Lu W
    Respir Res; 2023 Mar; 24(1):73. PubMed ID: 36899372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying chronic obstructive pulmonary disease from integrative omics and clustering in lung tissue.
    Hobbs BD; Morrow JD; Wang XW; Liu YY; DeMeo DL; Hersh CP; Celli BR; Bueno R; Criner GJ; Silverman EK; Cho MH
    BMC Pulm Med; 2023 Apr; 23(1):115. PubMed ID: 37041558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COPD subtypes identified by network-based clustering of blood gene expression.
    Chang Y; Glass K; Liu YY; Silverman EK; Crapo JD; Tal-Singer R; Bowler R; Dy J; Cho M; Castaldi P
    Genomics; 2016 Mar; 107(2-3):51-58. PubMed ID: 26773458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-omics study on biomarker and pathway discovery of chronic obstructive pulmonary disease.
    Tang Y; Chen Z; Fang Z; Zhao J; Zhou Y; Tang C
    J Breath Res; 2021 Sep; 15(4):. PubMed ID: 34280912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clustering-based COPD subtypes have distinct longitudinal outcomes and multi-omics biomarkers.
    Gregory A; Xu Z; Pratte K; Lee S; Liu C; Chase R; Yun J; Saferali A; Hersh CP; Bowler R; Silverman E; Castaldi PJ; Boueiz A
    BMJ Open Respir Res; 2022 Aug; 9(1):. PubMed ID: 35999035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merged Affinity Network Association Clustering: Joint multi-omic/clinical clustering to identify disease endotypes.
    Tyler SR; Chun Y; Ribeiro VM; Grishina G; Grishin A; Hoffman GE; Do AN; Bunyavanich S
    Cell Rep; 2021 Apr; 35(2):108975. PubMed ID: 33852839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omics-Based Investigations of Breast Cancer.
    Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PaIRKAT: A pathway integrated regression-based kernel association test with applications to metabolomics and COPD phenotypes.
    Carpenter CM; Zhang W; Gillenwater L; Severn C; Ghosh T; Bowler R; Kechris K; Ghosh D
    PLoS Comput Biol; 2021 Oct; 17(10):e1008986. PubMed ID: 34679079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating Genetics, Transcriptomics, and Proteomics in Lung Tissue to Investigate Chronic Obstructive Pulmonary Disease.
    Zhang YH; Cho MH; Morrow JD; Castaldi PJ; Hersh CP; Midha MK; Hoopmann MR; Lutz SM; Moritz RL; Silverman EK
    Am J Respir Cell Mol Biol; 2023 Jun; 68(6):651-663. PubMed ID: 36780661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.
    Zatloukal J; Brat K; Neumannova K; Volakova E; Hejduk K; Kocova E; Kudela O; Kopecky M; Plutinsky M; Koblizek V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):325-356. PubMed ID: 33325455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BIOMEPOC Project: Personalized Biomarkers and Clinical Profiles in Chronic Obstructive Pulmonary Disease.
    Gea J; Pascual S; Castro-Acosta A; Hernández-Carcereny C; Castelo R; Márquez-Martín E; Montón C; Palou A; Faner R; Furlong LI; Seijo L; Sanz F; Torà M; Vilaplana C; Casadevall C; López-Campos JL; Monsó E; Peces-Barba G; Cosío BG; Agustí A; ;
    Arch Bronconeumol (Engl Ed); 2019 Feb; 55(2):93-99. PubMed ID: 30343952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.